Form 3 ABIOMED INC To: May 26 Filed by: Plano Matthew T.

0

Enter Wall Street with StreetInsider Premium. Claim your one week free trial here.


FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL DECLARATION OF BENEFICIAL OWNER OF THE SECURITIES

Filed under Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Companies Act 1940

OMB APPROVAL
OMB number: 3235-0104
Expired : December 31, 2014
Estimated average load
hours per response: 0.5

1. Name and address of reporting person
*


A/S ABIOMED, ​​INC.,
22 CHERRY HILL DRIVE

(Street)
2. Date of the event requiring a report (month/day/year)
05/26/2022

3. Issuer name
and
ticker or trading symbol


ABIOMED INC
[
NASD
]
4. Relationship between the reporting person(s) and the issuer

(Check all that apply)
Director 10% Owner
X Officer (indicate title below) Other (specify below)
VP, GLOBAL OPERATIONS
5. In case of modification, date of filing of the original (month/day/year)
6. Individual or joint/group filing (check the applicable row)
X Form filed by a reporting person
Form filed by more than one declarant
Table I – Beneficial Ownership Non-Derivative Securities
1. Collateral Title (Instr. 4) 2. Amount of beneficial ownership (Instr. 4) 3. Form of ownership: direct (D) or indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)

Par value of common shares of $0.01

9,642

D

Table II – Derivative Beneficial Ownership Securities
(for example, puts, calls, warrants, options, convertible securities)
1. Derived Title Title (Instr. 4) 2. Exercise date and expiry date (month/day/year) 3. Title and amount of the securities underlying the derivative securities (Instr. 4) 4. Conversion or exercise price of the derivative security 5. Form of ownership: direct (D) or indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Exercise date Expiration date Title Amount or number of shares

Stock option (call right)

(1)

05/16/2019 05/16/2028

Ordinary actions

2,000

381.97

D

Stock option (call right)

(1)

05/30/2020 05/30/2029

Ordinary actions

5,000

266.39

D

Stock option (call right)

(1)

05/29/2021 05/29/2030

Ordinary actions

2,765

223.9

D

Stock option (call right)

(1)

05/25/2022 05/25/2031

Ordinary actions

2,765

283.88

D

Explanation of answers:
/s/ Marc A. Began (by proxy) 01/06/2022
** Signature of the declarant Date
Reminder: Declare on a separate line for each category of securities of which you are the direct or indirect beneficial owner.
* If the form is completed by more than one declarant,
see
Section 4 (b)(v).
** Intentional inaccuracies or omissions of facts are federal criminal offenses
See
18 USC 1001 and 15 USC 78ff(a).
Note: Submit three copies of this form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for the procedure.
Persons responding to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.

limited power of attorney

The undersigned hereby appoints each of Todd A. Trapp, Marc A. Began and Michael Dube, signing separately, the true and lawful attorney of the undersigned for:

(1) sign for and on behalf of the undersigned, in his capacity as a director or officer of ABIOMED, ​​Inc. (the “Company”), Forms 3, 4 and 5 pursuant to Section 16(a) of the Securities Exchange Act 1934 and the rules thereunder;

(2) do and perform all acts for and on behalf of the undersigned which may be necessary or advisable to complete and execute such Form 3, 4 or 5 and timely file such Form with the United States Securities and Exchange Commission; United States and any stock exchange or similar authority; and

(3) take any other action of any kind in connection with the foregoing which, in the opinion of said agent, may be beneficial, in the best interest or legally required by the undersigned, it being understood that the documents signed by such attorney on behalf of the undersigned pursuant to this proxy shall be in such form and contain such terms and conditions as such attorney may approve in such attorney’s discretion.

The undersigned hereby grants to each such agent full power and authority to do and do any act and thing required, necessary or proper to be done in the exercise of any of the rights and powers granted by hereby, as fully for all purposes and purposes which the undersigned may or may do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such agent, or substitute or the substitutes of this agent, must do or cause to be done legally by virtue of this power of attorney and the rights and powers granted therein. The undersigned acknowledges that the above-mentioned agents, in acting in their capacity at the request of the undersigned, do not assume, nor does the Company assume, any of the responsibilities of the undersigned to comply with Section 16 of the Securities Exchange Act of 1934.

This Power of Attorney shall remain in full force until the undersigned is no longer required to file Forms 3, 4 and 5 relating to the undersigned’s holdings and dealings in securities issued by the Company, unless revoked earlier by the undersigned in a signed writing delivered to the above named agents.

IN WITNESS WHEREOF, this power of attorney was executed on May 25, 2022 and will remain in full force and effect until revoked in writing by the undersigned.

Signature: /s/ Matthew T. Plano

Print Name: Matthew T. Plano

Share.

Comments are closed.